Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2001-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Eicosapentaenoic Acid as long-term secondary prevention after ischemic stroke ; volume:4 ; number:1 ; day:11 ; month:6 ; year:2015 ; pages:1-5 ; date:12.2015
Clinical and translational medicine ; 4, Heft 1 (11.6.2015), 1-5, 12.2015
- Urheber
-
Nakase, Taizen
- Beteiligte Personen und Organisationen
-
Sasaki, Masahiro
Suzuki, Akifumi
SpringerLink (Online service)
- DOI
-
10.1186/s40169-015-0062-5
- URN
-
urn:nbn:de:1111-201602281040
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nakase, Taizen
- Sasaki, Masahiro
- Suzuki, Akifumi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Personalized approach to primary and secondary prevention of ischemic stroke
Factor XI Inhibitors: perspectives in primary and secondary prevention of ischemic stroke
Trends and cost structure of drug-based secondary prevention of ischemic strokes
Untangling areas of improvement in secondary prevention of ischemic stroke in patients with atrial fibrillation
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Community physicians’ knowledge of secondary prevention after ischemic stroke: a questionnaire survey in Shanxi Province, China
Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention
Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
Secondary prevention after ischaemic stroke: the ASPIRE-S study
Ethnic differences in ischemic stroke subtypes in young-onset stroke: the Stroke Prevention in Young Adults Study
Personalized approach to primary and secondary prevention of ischemic stroke
Factor XI Inhibitors: perspectives in primary and secondary prevention of ischemic stroke
Trends and cost structure of drug-based secondary prevention of ischemic strokes
Untangling areas of improvement in secondary prevention of ischemic stroke in patients with atrial fibrillation
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Community physicians’ knowledge of secondary prevention after ischemic stroke: a questionnaire survey in Shanxi Province, China
Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention
Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
Secondary prevention after ischaemic stroke: the ASPIRE-S study
Ethnic differences in ischemic stroke subtypes in young-onset stroke: the Stroke Prevention in Young Adults Study
Personalized approach to primary and secondary prevention of ischemic stroke
Factor XI Inhibitors: perspectives in primary and secondary prevention of ischemic stroke
Trends and cost structure of drug-based secondary prevention of ischemic strokes
Untangling areas of improvement in secondary prevention of ischemic stroke in patients with atrial fibrillation
Outcomes of non-vitamin K oral anticoagulants for secondary prevention in ischemic stroke with atrial fibrillation
Community physicians’ knowledge of secondary prevention after ischemic stroke: a questionnaire survey in Shanxi Province, China
Anticoagulation Adherence: Bridging the Gap between Acute Stroke Treatment and Long-Term Secondary Prevention
Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
Lobeglitazone, a novel thiazolidinedione, for secondary prevention in patients with ischemic stroke: a nationwide nested case-control study
Secondary prevention after ischaemic stroke: the ASPIRE-S study